Table 1 Clinical characteristics and genotypes of six inherited retinal disease patients with AluY insertion.

From: Identification of diagnostic challenges in RP1 Alu insertion and strategies for overcoming them

Patient ID

Sex

Initial symptom

Age at first symptom onset (yr)

Age at diagnosis (yr)

Clinical diagnosis

RP1 mutations

DNA

Amino acid

11

M

Color amblyopia

14

31

CD

c.[4052_4053ins328]; [5797 C > T]

p.[(Tyr1352AlafsTer9)]; [(Arg1933Ter)]

41

F

Decrease in visual acuity

unknown

6

RP

c.[4052_4053ins328]; [4196del;6353G > A]

p.[( Tyr1352AlafsTer9)]; [(Cys1399LeufsTer5;Ser2118Asn)]

89

F

Decrease in visual acuity, night blindness

6

7

RP

c.[4052_4053ins328]; [4196del;6353G > A]

p.[( Tyr1352AlafsTer9)]; [(Cys1399LeufsTer5;Ser2118Asn)]

271

F

Decrease in visual acuity, nystagmus

unknown

14

RP

c.[2398 A > T]; [4052_4053ins328]

p.[(Lys800Ter)]; [(Tyr1352AlafsTer9)]

275

F

Night blindness

8

31

RP

c.[4052_4053ins328]; [6181del]

p.[( Tyr1352AlafsTer9)]; [(Ile2061SerfsTer12)]

289

F

Decrease in visual acuity

7

38

RP

c.[4052_4053ins328]; [6181del]

p.[( Tyr1352AlafsTer9)]; [(Ile2061SerfsTer12)]

  1. CD, cone dystrophy; F, female; M, male; RP, retinitis pigmentosa.
  2. Reference sequences of RP1: NM_006269.1 and NP_006260.1.
  3. AluY, NM_006269.2(RP1):c.4052_4053ins328, p.(Tyr1352AlafsTer9).